Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1979 1
1980 4
1981 1
1982 3
1983 1
1985 3
1986 5
1987 4
1988 2
1989 1
1990 4
1991 2
1992 8
1993 7
1994 8
1995 4
1996 7
1997 7
1998 14
1999 6
2000 13
2001 25
2002 29
2003 34
2004 48
2005 51
2006 39
2007 59
2008 77
2009 97
2010 96
2011 135
2012 149
2013 172
2014 216
2015 259
2016 322
2017 365
2018 413
2019 472
2020 629
2021 702
2022 817
2023 783
2024 839
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,264 results

Results by year

Filters applied: . Clear all
Page 1
Medical methods for first trimester abortion.
Zhang J, Zhou K, Shan D, Luo X. Zhang J, et al. Among authors: zhou k. Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5. Cochrane Database Syst Rev. 2022. PMID: 35608608 Free PMC article. Review.
Chemoproteomic mapping of the glycolytic targetome in cancer cells.
Tian Y, Wan N, Zhang H, Shao C, Ding M, Bao Q, Hu H, Sun H, Liu C, Zhou K, Chen S, Wang G, Ye H, Hao H. Tian Y, et al. Among authors: zhou k. Nat Chem Biol. 2023 Dec;19(12):1480-1491. doi: 10.1038/s41589-023-01355-w. Epub 2023 Jun 15. Nat Chem Biol. 2023. PMID: 37322158
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.
Opat S, Tedeschi A, Hu B, Linton KM, McKay P, Leitch S, Coleman M, Zinzani PL, Jin J, Sun M, Sobieraj-Teague M, Browett P, Ke X, Thieblemont C, Ardeshna K, Bijou F, Walker P, Hawkes EA, Ho SJ, Zhou K, Liang Z, Xu J, Tankersley C, Delarue R, Co M, Trotman J. Opat S, et al. Among authors: zhou k. Blood Adv. 2023 Nov 28;7(22):6801-6811. doi: 10.1182/bloodadvances.2023010668. Blood Adv. 2023. PMID: 37682792 Free PMC article. Clinical Trial.
6,264 results